{"id":"https://openalex.org/W3019503863","doi":"https://doi.org/10.3390/ijms21082950","title":"Multiple Sclerosis Treatment and Melanoma Development","display_name":"Multiple Sclerosis Treatment and Melanoma Development","publication_year":2020,"publication_date":"2020-04-22","ids":{"openalex":"https://openalex.org/W3019503863","doi":"https://doi.org/10.3390/ijms21082950","mag":"3019503863","pmid":"https://pubmed.ncbi.nlm.nih.gov/32331328","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7216218"},"language":"en","primary_location":{"id":"doi:10.3390/ijms21082950","doi":"https://doi.org/10.3390/ijms21082950","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/ijms21082950","pdf_url":"https://www.mdpi.com/1422-0067/21/8/2950/pdf","source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1422-0067/21/8/2950/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022972016","display_name":"Maria Luigia Carbone","orcid":"https://orcid.org/0000-0002-3350-1210","observed_orcids":["https://orcid.org/0000-0002-3350-1210"]},"institutions":[{"id":"https://openalex.org/I4210116004","display_name":"Istituto Dermopatico dell'Immacolata","ror":"https://ror.org/02b5mfy68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Luigia Carbone","raw_affiliation_strings":["Laboratory of Experimental Immunology, IDI-IRCCS, 00167 Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Experimental Immunology, IDI-IRCCS, 00167 Rome, Italy","institution_ids":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005666712","display_name":"Pedro Miguel Lacal","orcid":"https://orcid.org/0000-0003-1166-4593","observed_orcids":["https://orcid.org/0000-0003-1166-4593"]},"institutions":[{"id":"https://openalex.org/I4210116004","display_name":"Istituto Dermopatico dell'Immacolata","ror":"https://ror.org/02b5mfy68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pedro Miguel Lacal","raw_affiliation_strings":["Laboratory of Molecular Oncology, IDI-IRCCS, 00167 Rome, Italy"],"raw_orcid":"https://orcid.org/0000-0003-1166-4593","affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Oncology, IDI-IRCCS, 00167 Rome, Italy","institution_ids":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080780100","display_name":"Serena Messinese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116004","display_name":"Istituto Dermopatico dell'Immacolata","ror":"https://ror.org/02b5mfy68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Serena Messinese","raw_affiliation_strings":["I Dermatology Department, IDI-IRCCS, 00167 Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I Dermatology Department, IDI-IRCCS, 00167 Rome, Italy","institution_ids":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063199948","display_name":"Laura De Giglio","orcid":"https://orcid.org/0000-0001-9018-7320","observed_orcids":["https://orcid.org/0000-0001-9018-7320"]},"institutions":[{"id":"https://openalex.org/I4210097502","display_name":"Ospedale San Filippo Neri","ror":"https://ror.org/00qt4k071","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097502"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura De Giglio","raw_affiliation_strings":["Medicine Department, Neurology Unit, San Filippo Neri Hospital, 00135 Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine Department, Neurology Unit, San Filippo Neri Hospital, 00135 Rome, Italy","institution_ids":["https://openalex.org/I4210097502"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083385630","display_name":"Carlo Pozzilli","orcid":"https://orcid.org/0000-0002-6360-4798","observed_orcids":["https://orcid.org/0000-0002-6360-4798"]},"institutions":[{"id":"https://openalex.org/I4210125574","display_name":"Azienda Ospedaliera Sant'Andrea","ror":"https://ror.org/032298f51","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210125574"]},{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carlo Pozzilli","raw_affiliation_strings":["Department of Human Neurosciences, Sant\u2019Andrea Hospital, MS Centre, Sapienza University, 00189 Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Neurosciences, Sant\u2019Andrea Hospital, MS Centre, Sapienza University, 00189 Rome, Italy","institution_ids":["https://openalex.org/I4210125574","https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102836020","display_name":"Severino Persechino","orcid":"https://orcid.org/0000-0002-3728-5877","observed_orcids":["https://orcid.org/0000-0002-3728-5877"]},"institutions":[{"id":"https://openalex.org/I4210125574","display_name":"Azienda Ospedaliera Sant'Andrea","ror":"https://ror.org/032298f51","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210125574"]},{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Severino Persechino","raw_affiliation_strings":["NESMOS Department, Dermatology Unit, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NESMOS Department, Dermatology Unit, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy","institution_ids":["https://openalex.org/I4210125574","https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Cinzia Mazzanti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116004","display_name":"Istituto Dermopatico dell'Immacolata","ror":"https://ror.org/02b5mfy68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cinzia Mazzanti","raw_affiliation_strings":["I Dermatology Department, IDI-IRCCS, 00167 Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I Dermatology Department, IDI-IRCCS, 00167 Rome, Italy","institution_ids":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024609040","display_name":"Cristina Maria Failla","orcid":"https://orcid.org/0000-0001-5991-8914","observed_orcids":["https://orcid.org/0000-0001-5991-8914"]},"institutions":[{"id":"https://openalex.org/I4210116004","display_name":"Istituto Dermopatico dell'Immacolata","ror":"https://ror.org/02b5mfy68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Cristina Maria Failla","raw_affiliation_strings":["Laboratory of Experimental Immunology, IDI-IRCCS, 00167 Rome, Italy"],"raw_orcid":"https://orcid.org/0000-0001-5991-8914","affiliations":[{"raw_affiliation_string":"Laboratory of Experimental Immunology, IDI-IRCCS, 00167 Rome, Italy","institution_ids":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083362670","display_name":"Gianluca Pagnanelli","orcid":"https://orcid.org/0000-0003-0961-6779","observed_orcids":["https://orcid.org/0000-0003-0961-6779"]},"institutions":[{"id":"https://openalex.org/I4210116004","display_name":"Istituto Dermopatico dell'Immacolata","ror":"https://ror.org/02b5mfy68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gianluca Pagnanelli","raw_affiliation_strings":["I Dermatology Department, IDI-IRCCS, 00167 Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I Dermatology Department, IDI-IRCCS, 00167 Rome, Italy","institution_ids":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5024609040"],"corresponding_institution_ids":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"],"apc_list":{"value":2000,"currency":"CHF","value_usd":2112},"apc_paid":{"value":2000,"currency":"CHF","value_usd":2112},"fwci":1.387,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.82595636,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"21","issue":"8","first_page":"2950","last_page":"2950"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.6851000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.6851000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.17980000376701355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.04100000113248825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cutaneous-melanoma","display_name":"cutaneous melanoma","score":0.8130000233650208},{"id":"https://openalex.org/keywords/natalizumab","display_name":"natalizumab","score":0.9610000252723694},{"id":"https://openalex.org/keywords/fingolimod","display_name":"fingolimod","score":1.0},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.8209999799728394},{"id":"https://openalex.org/keywords/atypical-naevi","display_name":"atypical naevi","score":0.878000020980835},{"id":"https://openalex.org/keywords/vegf-a","display_name":"VEGF-A","score":0.8579999804496765},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7689999938011169},{"id":"https://openalex.org/keywords/melanoma-cell-migration","display_name":"melanoma cell migration","score":0.8659999966621399},{"id":"https://openalex.org/keywords/melanoma-cell-proliferation","display_name":"melanoma cell proliferation","score":0.9049999713897705},{"id":"https://openalex.org/keywords/leukocyte-infiltration","display_name":"leukocyte infiltration","score":0.6880000233650208},{"id":"https://openalex.org/keywords/drug-induced-malignancy","display_name":"drug-induced malignancy","score":0.5080000162124634}],"concepts":[{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.9671794176101685},{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.9489837288856506},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.700933575630188},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6977871060371399},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6079879999160767},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5780869722366333},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5172098875045776},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3891819417476654},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3380282521247864},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33558961749076843}],"mesh":[{"descriptor_ui":"D000068876","descriptor_name":"Fingolimod Hydrochloride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068876","descriptor_name":"Fingolimod Hydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000069442","descriptor_name":"Natalizumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069442","descriptor_name":"Natalizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000096142","descriptor_name":"Cutaneous Malignant Melanoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001706","descriptor_name":"Biopsy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004198","descriptor_name":"Disease Susceptibility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.3390/ijms21082950","doi":"https://doi.org/10.3390/ijms21082950","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/ijms21082950","pdf_url":"https://www.mdpi.com/1422-0067/21/8/2950/pdf","source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},{"id":"pmid:32331328","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32331328","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of molecular sciences","raw_type":"Case Reports"},{"id":"pmh:oai:pubmedcentral.nih.gov:7216218","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7216218/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Mol Sci","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:1651a2c370c04fc1886c8c8b9d153430","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1651a2c370c04fc1886c8c8b9d153430","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Molecular Sciences, Vol 21, Iss 2950, p 2950 (2020)","raw_type":"article"},{"id":"pmh:oai:iris.uniroma1.it:11573/1453299","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11573/1453299","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3390/ijms21082950","doi":"https://doi.org/10.3390/ijms21082950","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/ijms21082950","pdf_url":"https://www.mdpi.com/1422-0067/21/8/2950/pdf","source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2076520454","display_name":null,"funder_award_id":"2018-","funder_id":"https://openalex.org/F4320321781","funder_display_name":"Ministero della Salute"}],"funders":[{"id":"https://openalex.org/F4320321781","display_name":"Ministero della Salute","ror":"https://ror.org/00789fa95"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3019503863.pdf","grobid_xml":"https://content.openalex.org/works/W3019503863.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W602919538","https://openalex.org/W1516353866","https://openalex.org/W1982146607","https://openalex.org/W1984179269","https://openalex.org/W1986991730","https://openalex.org/W2009081283","https://openalex.org/W2009769276","https://openalex.org/W2025227255","https://openalex.org/W2035759329","https://openalex.org/W2036097435","https://openalex.org/W2047122961","https://openalex.org/W2064888273","https://openalex.org/W2074864913","https://openalex.org/W2102478723","https://openalex.org/W2103758700","https://openalex.org/W2104948944","https://openalex.org/W2108652737","https://openalex.org/W2118374233","https://openalex.org/W2125036060","https://openalex.org/W2141511211","https://openalex.org/W2144910131","https://openalex.org/W2151340435","https://openalex.org/W2180856345","https://openalex.org/W2555514711","https://openalex.org/W2559197918","https://openalex.org/W2562388019","https://openalex.org/W2587699888","https://openalex.org/W2590828263","https://openalex.org/W2650090085","https://openalex.org/W2650093893","https://openalex.org/W2741956852","https://openalex.org/W2743911010","https://openalex.org/W2767522821","https://openalex.org/W2899336877","https://openalex.org/W2905167999","https://openalex.org/W2921434986","https://openalex.org/W6676126104"],"related_works":["https://openalex.org/W2025227255","https://openalex.org/W1982146607","https://openalex.org/W2118374233","https://openalex.org/W2180856345","https://openalex.org/W2741956852","https://openalex.org/W2562388019","https://openalex.org/W2141511211","https://openalex.org/W2587699888","https://openalex.org/W4386287296","https://openalex.org/W2559197918"],"abstract_inverted_index":{"Therapy":[0],"of":[1,19,30,33,64,73,146,150],"multiple":[2],"sclerosis":[3],"(MS)":[4],"with":[5,16,50],"disease-modifying":[6],"agents":[7],"such":[8],"as":[9,70,72],"natalizumab":[10,51,103,151],"or":[11,112,152],"fingolimod":[12,55,105,133,153],"has":[13],"been":[14],"associated":[15],"the":[17,62,81,118,144,160],"development":[18],"cutaneous":[20],"melanoma.":[21],"Here":[22],"we":[23,60,86],"briefly":[24],"revise":[25],"literature":[26],"data":[27,140],"and":[28,42,54,67,90,98,104],"report":[29],"a":[31,34,40,147],"case":[32],"48-year":[35],"old":[36],"woman":[37],"who":[38],"developed":[39],"melanoma":[41,83,95,128,155,168],"several":[43],"atypical":[44],"naevi":[45],"after":[46,132],"sub":[47],"sequential":[48],"treatment":[49],"(1":[52],"year)":[53],"(7":[56],"years).":[57],"By":[58],"immunohistochemistry":[59],"observed":[61],"presence":[63],"T":[65],"cells":[66],"leukocyte":[68],"infiltration":[69],"well":[71],"vascular":[74],"endothelial":[75],"growth":[76],"factor":[77],"(VEGF)-A":[78],"expression":[79,92],"in":[80,93,126,138],"patient":[82],"biopsy.":[84],"Then,":[85],"analyzed":[87],"proliferation,":[88],"migration":[89,115],"VEGF-A":[91,122],"three":[94],"cell":[96,108,114,119,129],"lines":[97],"found":[99],"out":[100],"that":[101],"both":[102],"inhibited":[106],"tumor":[107,161],"proliferation":[109],"but":[110,157],"promoted":[111],"blocked":[113],"depending":[116],"on":[117,154,159],"line":[120,130],"examined.":[121],"secretion":[123],"was":[124],"augmented":[125],"one":[127],"only":[131],"treatment.":[134],"In":[135],"conclusion,":[136],"our":[137],"vitro":[139],"do":[141],"not":[142],"support":[143],"hypothesis":[145],"direct":[148],"action":[149],"progression":[156],"acting":[158],"microenvironment":[162],"these":[163],"treatments":[164],"could":[165],"indirectly":[166],"favor":[167],"evolution.":[169]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-05-01T00:00:00"}